+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 40Years
FEMALE
ID06763926

Comparison of Intranasal Nafarelin and Subcutaneous Triptorelin for Triggering Final Oocyte Maturation in Women Undergoing Fertility Preservation with Ovarian Stimulation

Led by Fundacion Dexeus · Updated on 2026-10-15

154

Participants Needed

5

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a non-inferiority randomized controlled trial to compare subcutaneous triptorelin and intranasal nafarelin for triggering final oocyte maturation in women undergoing fertility preservation cycles with oocyte cryopreservation. The study aims to determine if intranasal nafarelin is not significantly less effective than subcutaneous triptorelin in producing mature oocytes, with a focus on the number of mature metaphase 2 oocytes collected. This trial is sponsored by Fundacion Dexeus and focuses on women aged 18 to 40 undergoing ovarian stimulation. Participants receive progesterone-primed ovarian stimulation using any commercially available gonadotropin preparation. Once they have at least three follicles 18 mm or larger, they are randomly assigned to one of two groups. One group receives 200 micrograms of subcutaneous triptorelin 34 to 36 hours before planned oocyte collection, while the other group receives 800 micrograms of intranasal nafarelin at the same time before collection. During the study, participants undergo hormonal monitoring including serum FSH, LH, and progesterone levels around the trigger and oocyte retrieval times. Researchers record the total and mature oocytes retrieved, incidence of ovarian hyperstimulation syndrome, participant-reported pain, medication ease of use, preference, and adverse events. The primary outcome is measured until study completion, which lasts on average 10 to 20 days. Participants are closely monitored throughout the ovarian stimulation and retrieval process to assess safety and effectiveness signals.

CONDITIONS

Brief Title

Intranasal Nafarelin For Triggering Oocyte Maturation

Research Team

N

Nikolaos P Polyzos, MD, PhD

I

Ignacio Rodríguez, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here